South Korea
· Delayed Price · Currency is KRW Median Diagnostics Statistics
Total Valuation
Median Diagnostics has a market cap or net worth of KRW 24.43 billion.
| Market Cap | 24.43B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Median Diagnostics has 1.75 million shares outstanding.
| Shares Outstanding | 1.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.88% |
| Owned by Institutions (%) | n/a |
| Float | 390,970 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.04 |
| PB Ratio | 2.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31, with a Debt / Equity ratio of 70.39.
| Current Ratio | 4.31 |
| Quick Ratio | 3.20 |
| Debt / Equity | 70.39 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | -3.07 |
| Interest Coverage | 2.99 |
Financial Efficiency
Return on equity (ROE) is -8.16% and return on invested capital (ROIC) is 6.02%.
| Return on Equity (ROE) | -8.16% |
| Return on Assets (ROA) | 4.70% |
| Return on Capital (ROIC) | 6.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -12.56% |
| 50-Day Moving Average | 13,534.00 |
| 200-Day Moving Average | 14,472.50 |
| Relative Strength Index (RSI) | 53.77 |
| Average Volume (20 Days) | 20 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Median Diagnostics had revenue of KRW 7.86 billion and -567.58 million in losses. Loss per share was -496.00.
| Revenue | 7.86B |
| Gross Profit | 4.95B |
| Operating Income | 1.17B |
| Pretax Income | -1.17B |
| Net Income | -567.58M |
| EBITDA | 1.59B |
| EBIT | 1.17B |
| Loss Per Share | -496.00 |
Balance Sheet
The company has 3.66 billion in cash and 4.33 billion in debt, giving a net cash position of -672.04 million or -384.79 per share.
| Cash & Cash Equivalents | 3.66B |
| Total Debt | 4.33B |
| Net Cash | -672.04M |
| Net Cash Per Share | -384.79 |
| Equity (Book Value) | 6.15B |
| Book Value Per Share | 5,378.46 |
| Working Capital | 5.11B |
Cash Flow
In the last 12 months, operating cash flow was -6.05 million and capital expenditures -1.41 billion, giving a free cash flow of -1.41 billion.
| Operating Cash Flow | -6.05M |
| Capital Expenditures | -1.41B |
| Free Cash Flow | -1.41B |
| FCF Per Share | -809.17 |
Margins
Gross margin is 63.01%, with operating and profit margins of 14.86% and -7.22%.
| Gross Margin | 63.01% |
| Operating Margin | 14.86% |
| Pretax Margin | -14.93% |
| Profit Margin | -7.22% |
| EBITDA Margin | 20.25% |
| EBIT Margin | 14.86% |
| FCF Margin | -17.98% |
Dividends & Yields
Median Diagnostics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.55% |
| FCF Yield | -5.78% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |